These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. Jensen TO; Schmidt H; Møller HJ; Høyer M; Maniecki MB; Sjoegren P; Christensen IJ; Steiniche T J Clin Oncol; 2009 Jul; 27(20):3330-7. PubMed ID: 19528371 [TBL] [Abstract][Full Text] [Related]
5. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476 [TBL] [Abstract][Full Text] [Related]
6. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926 [TBL] [Abstract][Full Text] [Related]
8. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405 [TBL] [Abstract][Full Text] [Related]
9. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112 [TBL] [Abstract][Full Text] [Related]
10. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276 [TBL] [Abstract][Full Text] [Related]
13. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood. Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692 [TBL] [Abstract][Full Text] [Related]
14. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure. Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171 [TBL] [Abstract][Full Text] [Related]
15. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis]. Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320 [TBL] [Abstract][Full Text] [Related]